Cargando…
Correction to: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832638/ https://www.ncbi.nlm.nih.gov/pubmed/35144657 http://dx.doi.org/10.1186/s13063-022-06079-1 |
| _version_ | 1784648764604022784 |
|---|---|
| author | Leung, Christopher Kai Shun Ren, Seraph Tianmin Chan, Poemen Pui Man Wan, Kelvin Ho Nam Kam, Aziz Ka Wai Lai, Gilda Wing Ki Chiu, Vivian Sheung Man Ko, Match Wai Lun Yiu, Cedric Ka Fai Yu, Marco Chak Yan |
| author_facet | Leung, Christopher Kai Shun Ren, Seraph Tianmin Chan, Poemen Pui Man Wan, Kelvin Ho Nam Kam, Aziz Ka Wai Lai, Gilda Wing Ki Chiu, Vivian Sheung Man Ko, Match Wai Lun Yiu, Cedric Ka Fai Yu, Marco Chak Yan |
| author_sort | Leung, Christopher Kai Shun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8832638 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88326382022-02-11 Correction to: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial Leung, Christopher Kai Shun Ren, Seraph Tianmin Chan, Poemen Pui Man Wan, Kelvin Ho Nam Kam, Aziz Ka Wai Lai, Gilda Wing Ki Chiu, Vivian Sheung Man Ko, Match Wai Lun Yiu, Cedric Ka Fai Yu, Marco Chak Yan Trials Correction BioMed Central 2022-02-10 /pmc/articles/PMC8832638/ /pubmed/35144657 http://dx.doi.org/10.1186/s13063-022-06079-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Leung, Christopher Kai Shun Ren, Seraph Tianmin Chan, Poemen Pui Man Wan, Kelvin Ho Nam Kam, Aziz Ka Wai Lai, Gilda Wing Ki Chiu, Vivian Sheung Man Ko, Match Wai Lun Yiu, Cedric Ka Fai Yu, Marco Chak Yan Correction to: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial |
| title | Correction to: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial |
| title_full | Correction to: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial |
| title_fullStr | Correction to: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial |
| title_full_unstemmed | Correction to: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial |
| title_short | Correction to: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial |
| title_sort | correction to: nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832638/ https://www.ncbi.nlm.nih.gov/pubmed/35144657 http://dx.doi.org/10.1186/s13063-022-06079-1 |
| work_keys_str_mv | AT leungchristopherkaishun correctiontonicotinamideribosideasaneuroprotectivetherapyforglaucomastudyprotocolforarandomizeddoubleblindplacebocontroltrial AT renseraphtianmin correctiontonicotinamideribosideasaneuroprotectivetherapyforglaucomastudyprotocolforarandomizeddoubleblindplacebocontroltrial AT chanpoemenpuiman correctiontonicotinamideribosideasaneuroprotectivetherapyforglaucomastudyprotocolforarandomizeddoubleblindplacebocontroltrial AT wankelvinhonam correctiontonicotinamideribosideasaneuroprotectivetherapyforglaucomastudyprotocolforarandomizeddoubleblindplacebocontroltrial AT kamazizkawai correctiontonicotinamideribosideasaneuroprotectivetherapyforglaucomastudyprotocolforarandomizeddoubleblindplacebocontroltrial AT laigildawingki correctiontonicotinamideribosideasaneuroprotectivetherapyforglaucomastudyprotocolforarandomizeddoubleblindplacebocontroltrial AT chiuviviansheungman correctiontonicotinamideribosideasaneuroprotectivetherapyforglaucomastudyprotocolforarandomizeddoubleblindplacebocontroltrial AT komatchwailun correctiontonicotinamideribosideasaneuroprotectivetherapyforglaucomastudyprotocolforarandomizeddoubleblindplacebocontroltrial AT yiucedrickafai correctiontonicotinamideribosideasaneuroprotectivetherapyforglaucomastudyprotocolforarandomizeddoubleblindplacebocontroltrial AT yumarcochakyan correctiontonicotinamideribosideasaneuroprotectivetherapyforglaucomastudyprotocolforarandomizeddoubleblindplacebocontroltrial |